Mary Elizabeth Henderson serves as Executive at Jazz Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Mary Elizabeth Henderson has executed 6 insider transactions totaling $532.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 16, 2026 involved receiving (via award) 10,116 shares valued at $0.
Mary Elizabeth Henderson currently holds 29,624 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Elizabeth Henderson has been a net seller of JAZZ stock. They have purchased $0 and sold $532.1K worth of shares.
Mary Elizabeth Henderson's most recent insider trade was on Jan 16, 2026, when they sold 10,116 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $169.51 |
| Discretionary |
| Nov 19, 2025 | JAZZ | $240.1K | Disposition | 1,331 | $180.40 | Discretionary |
| Sep 6, 2024 | JAZZ | $152.7K | Sale | 1,410 | $108.30 | Discretionary |
| Mar 1, 2024 | JAZZ | $0 | Award | 5,178 | $N/A | Discretionary |
| Aug 11, 2023 | JAZZ | $0 | Award | 10,763 | $N/A | Discretionary |